Telehealth startup PWNHealth will provide physician oversight services to Sema4's recently launched CarrierChek product, allowing for a nationwide rollout.
The alliance will combine the two firms' technologies and know-how to provide doctors with insights into patients' health status.
Vendors DNAnexus and Saphetor hope to create a seamless platform for genome-based biomarker discovery and interpretation.
The services will couple NEB's reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and engineering know-how.
The newly announced tie-up wants to alleviate the shortage of bioinformaticists by taking over data management and storage for genomics researchers.
The company will provide its molecular thyroid tests to researchers at Einstein Medical Center of Philadelphia.
GATC Biotech said it selected Bluebee's platform for its service because of its increased automation and flexibility.
Under the terms of the agreement, N-of-One will provide clinical interpretation services for CompanionDx's targeted next generation sequencing-based tests.
Amarantus will use its LymPro Test to evaluate the pharmacodynamic effect of Anavex 2-73 and Anavex Plus on the expression of the biomarker CD69.
NEW YORK (GenomeWeb) – N-of-One said today that it has signed an agreement to provide clinical interpretation support for the Mayo Clinic's molecular diagnostics testing.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.